By Bhanvi Satija and Sneha S K MADRID, Oct 26 (Reuters) – An experimental drug for a hard-to-treat bone cancer, being developed by Hansoh Pharmaceutical and GSK, helped patients live longer without
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
By Manya Saini and Echo Wang Oct 26 (Reuters) - Anthropic disclosed steep losses and…
By Manya Saini and Echo Wang Oct 26 (Reuters) - Anthropic disclosed steep losses and…
(Adds fresh comment on Russia from Student List in paragraphs 13-14) * Moscow hopes Serbia's…
VIDEO SHOWS: THOMAS VAN TONDER BECOMES THE FIRST PERSON TO CROSS 600 MONKEY BARS SUSPENDED…
AUDI: DELEGATION VISITED GEORGIA TO TAKE FORWARD NEGOTIATIONS REGARDING PLANNED PLANT, DURING THESE DISCUSSIONS WE…
By Stephen Nellis SAN FRANCISCO, Oct 26 (Reuters) - Unconventional AI, the US hardware startup…